On Thursday shares of Basic Energy Services, Inc. (NYSE:BAS) closed at $7.09. Company’s sales growth for last 5 years was 23.10% and EPS growth for next 5 years is recorded as 6.00%. Basic Energy Services, Inc. (NYSE:BAS) monthly performance isRead More

Marvell Technology Group Ltd. (NASDAQ:MRVL) announced it will conduct a conference call following the release of its fourth fiscal quarter of 2015 financial results on Thursday, February 19, 2015, at 1:45 p.m. Pacific Time. On Monday shares of Marvell TechnologyRead More

Integrated Device Technology, Inc. (NASDAQ:IDTI) on 13 January expanded its comprehensive timing portfolio with the introduction of two new families of crystal oscillators. The IDT XU and XL families offer unparalleled features and flexibility at an industry-leading price-vs.-performance ratio. TheRead More

ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) on 14 January announced its key strategic objectives for 2015 as well as its aim to increase research and development (R&D) activities and expand business development initiatives. Details will be discussed at the annual J.P. MorganRead More

KeyCorp (NYSE:KEY) will announce fourth quarter 2014 earnings on Thursday, January 22, 2015, before the market opens. A conference call will be held at 9:00 a.m. ET to review financial results, strategy and outlook. KeyCorp. (NYSE:KEY) in last trading activityRead More

Novavax, Inc. (NASDAQ:NVAX) on Nov. 20 announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Novavax’ RSV F-Protein nanoparticle vaccine candidate (RSV F vaccine) for protection of infants via maternal immunization. Maternal immunization representsRead More

On 19 November Avon Products, Inc.(AVP) has announced a series of changes to the company’s management structure so as to support its multiyear turnaround plan. Avon Products Inc. (NYSE:AVP) in last trading activity moved up 1.77% to close at $9.78.Read More

United Therapeutics Corporation (NASDAQ:UTHR) COO Roger Jeffs unloaded 10,000 shares of United Therapeutics stock in a transaction that occurred on Tuesday, November 25th. The stock was sold at an average price of $131.30, for a total transaction of $1,313,000.00. FollowingRead More

On 13 November Phoenix New Media Limited (NYSE:FENG) announced its unaudited financial results for the third quarter ended September 30, 2014. Total revenues for the third quarter of 2014 increased by 14.0% to RMB431.8 million (US$70.3 million) fromRMB378.7 million inRead More

Merck & Co. Inc. (NYSE:MRK) inked a deal with Pfizer Inc. to co-develop and co-commercialize Merck KGaA’s investigational anti-PD-L1 antibody, MSB0010718C, as a potential treatment for multiple types of tumor. Merck & Co. Inc. (NYSE:MRK) in last trading activity movedRead More